SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-08-069729
Filing Date
2008-11-10
Accepted
2008-11-10 16:20:12
Documents
4
Period of Report
2008-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a08-28032_18k.htm 8-K 28303
2 EX-10.1 a08-28032_1ex10d1.htm EX-10.1 25891
3 EX-99.1 a08-28032_1ex99d1.htm EX-99.1 243990
4 GRAPHIC g280321mm01i001.jpg GRAPHIC 6409
  Complete submission text file 0001104659-08-069729.txt   308916
Mailing Address 1400 SEAPORT BLVD. REDWOOD CITY CA 94063
Business Address 1400 SEAPORT BLVD. REDWOOD CITY CA 94063 650-454-1000
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 081175905
SIC: 2836 Biological Products, (No Diagnostic Substances)